NCT03997058

Brief Summary

Maintenance hemodialysis (MHD) is one of the most important treatments for patients with end-stage renal failure. Studies have found that insomnia is widespread in MHD patients, affecting their quality of life. Auricular acupoint pressing is an effective traditional Chinese medicine treatment for insomnia. This study compared the effects of auricular acupoint pressing and oral estazolam on insomnia in patients with MHD, and evaluated the possibility of auricular acupoint pressing to reduce the incidence of adverse events by improving insomnia in patients with MHD, and to explore the insomnia of MHD patients treated with TCM characteristics. The role and efficacy provide a basis for the treatment of sleep disorders by Chinese medicine.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 25, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

December 16, 2020

Status Verified

December 1, 2020

Enrollment Period

1.3 years

First QC Date

June 23, 2019

Last Update Submit

December 12, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pittsburgh sleep quality index(PSQI)score

    June 1, 2019 to June 1, 2021

  • Mortality rate

    June 1, 2019 to June 1, 2021

Secondary Outcomes (3)

  • Incidence of cardiovascular events

    June 1, 2019 to June 1, 2021

  • Cerebrovascular accident rate

    June 1, 2019 to June 1, 2021

  • Gastrointestinal bleeding rate

    June 1, 2019 to June 1, 2021

Other Outcomes (1)

  • Hypersensitive C-reactive protein concentration

    June 1, 2019 to June 1, 2021

Study Arms (4)

Control group

NO INTERVENTION

Auricular acupoint pressing group

EXPERIMENTAL
Other: Auricular point pressure therapy

Oral estazolam group

ACTIVE COMPARATOR
Drug: Oral estazolam medication

Combined treatment group

ACTIVE COMPARATOR
Other: Auricular point pressure therapyDrug: Oral estazolam medication

Interventions

Use a hard and smooth pill to adhere to the center of the 0.7×0.7cm tape. Hold the puncture clip on the part of the ear which is selected, and give appropriate pressure (揉) to make the patient have heat, hemp, Swelling and painful feeling; patients with sputum press 3-5 times a day, each time 1-2 minutes per hole, and must be pressed once every 15-30 minutes before going to bed every night. Press the point pressure method (press the ear point with a fingertip and press it loosely, each interval is 0.5 seconds. It is better for the patient to feel the swelling and slightly heavy tingling, and the force should not be too heavy. Generally, each time the hole can be pressed 27 times. Each time one side of the ear is selected, the two ear points are used alternately, staying in the summer for 1-3 days, and staying in the winter for 3-7 days.It is not appropriate to have local inflammation of the auricle, frostbite or surface skin ulceration.

Auricular acupoint pressing groupCombined treatment group

The first dose was started from 0.5mg, qn, and taken at 30min-1h before going to bed. If the dose is not effective, gradually increase the amount to 2mg, qn. If the patient has drug-induced liver damage and respiratory depression, it is necessary to stop the drug immediately. Hemorrhoids avoid drinking alcohol during medication.

Combined treatment groupOral estazolam group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-90 years old,received maintenance hemodialysis treatment for more than 1 year, no history of surgical trauma, infection, trauma in the past 3 months; 2.the current condition is stable, the heart function is grade I, no limb paralysis, speech disadvantages and other sequelae; 3.Informed consent volunteer to participate in this experiment.

You may not qualify if:

  • At present, dialysis is inadequate, water and sodium retention is severe;
  • combined with severe cardiovascular disease, sequelae of cerebral infarction or history of cerebral hemorrhage, history of COPD, history of myasthenia gravis, history of angle-closure glaucoma, blood system disease, mental system disease or other systemic The disease can not be matched with the experimenter;
  • poor compliance or poor medical attitude;
  • severe hearing or vision loss, or a very low level of education, can not match the experiment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Guangzho University of Chinese Medicine

Guangzhou, Guangdong, 510405, China

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Negative control group, auricular acupoint pressing group, estazolam group, combined treatment group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 23, 2019

First Posted

June 25, 2019

Study Start

March 1, 2019

Primary Completion

June 1, 2020

Study Completion

January 1, 2021

Last Updated

December 16, 2020

Record last verified: 2020-12

Locations